Patent · US Expired

Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease

USRE38132E1 · kind E1 · reissue

1Cited by
11References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2002
Grant dateJun 3, 2003
Priority date
Expiry dateJun 12, 2022

Classification

  • Technology area (CPC —)General

Abstract

A method treating or preventing inflammatory and immune cell-mediated diseases by the administration of certain novel and known small molecules. Exemplary of the novel compounds are those of the following structural formulas:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.